Trade OCGN

Ocugen, Inc.

-

00:00:00

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Read more...

OCGN
Trading Specifications

Digits

2

Point

0.01

Spread

 
floating

Contract Size

1

Volume Min

1

Volume Max

10,000

Volume Step

1

Swap Long (Points)

 
-0.06

Swap Short (Points)

-0.03
Available on
MT5, TV, cTrader
Last update at April 19, 20:08 GMT+3
*Data Source: MT5 Server Prime Account Pricing

1D Change

1.575%

Why BlackBull Markets?

26k+

Tradable Assets

1:500

Leverage up to

Regulated

Multi-Regulated

24/7

Customer Support

$0

No Minimum Deposit

Margin Calculator

Calculation Results

Current Price

1.29

Required Margin

Converted Currency

Required Margin

Account Base Currency

Profit/Loss Calculator

PIP Value:

Stop loss in PIPs

Stop loss at:

Take profit in PIPs

Take profit at:

Join Now